Mandi Mears
Family · Conway, ARNPI 1710220959
Payments from drug & device makers
Across 209 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$641
- AbbVie$491
- Abbott$381
- Amgen$294
- Pfizer$211
- Lilly USA, LLC$210
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,818100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 37 | $641 |
| AbbVie | 34 | $491 |
| Abbott | 18 | $381 |
| Amgen | 16 | $294 |
| Pfizer | 12 | $211 |
| Lilly USA, LLC | 15 | $210 |
| Novo Nordisk | 12 | $202 |
| Corium, LLC | 8 | $163 |
| Vertex | 1 | $121 |
| Boehringer Ingelheim | 6 | $114 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $113 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $109 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $97 |
| Dexcom, Inc. | 4 | $89 |
| Antares Pharma, Inc. | 4 | $83 |
| Astellas Pharma US Inc | 3 | $70 |
| Phathom Pharmaceuticals, Inc. | 5 | $66 |
| Exact Sciences | 3 | $55 |
| Sanofi Pasteur Inc. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| GSK | 2 | $32 |
| Novartis | 2 | $30 |
| Shield Therapeutics Inc | 2 | $30 |
| Nestle Healthcare Nutrition Inc. | 2 | $26 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Phadia US Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JOURNAVX$121
How this compares
$3,818 in reported general payments places this provider in the 90th percentile of 2,103 family providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 69 | $69,955 |
| OzempicSemaglutide | 53 | $55,967 |
| TrulicityDulaglutide | 22 | $19,568 |
| XareltoRivaroxaban | 19 | $16,725 |
| EliquisApixaban | 17 | $16,205 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $10,931 |
| FarxigaDapagliflozin Propanediol | 11 | $10,257 |
| SymbicortBudesonide/Formoterol Fumarate | 24 | $7,880 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $6,009 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 27 | $5,830 |
| Diclofenac Sodium | 108 | $1,933 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 70 | $1,773 |
| Levothyroxine Sodium | 250 | $1,313 |
| Pantoprazole Sodium | 184 | $1,303 |
| Gabapentin | 101 | $1,044 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $210 | $89,52391 claims |
| Novo NordiskOzempic | $202 | $55,96753 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $641 | $29,06946 claims |
| PfizerEliquis | $211 | $16,20517 claims |
| Boehringer IngelheimStiolto Respimat | $114 | $6,00911 claims |
| AbbVieSynthroid | $491 | $82220 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,103 family providers in Arkansas.
Other family in Conway
- Meghan MallettConway$25K
- Sheila ForresterConway$17K
- Elana RussellConway$17K
- Donald KulbethConway$12K
- Kayla JohnsonConway$9K
- Crystal BrownConway$9K
- Leah CarringtonRogers$1.6M
- Nina CopelandFort Smith$207K
- Stefanie BrackinJonesboro$51K
- Amanda DavisFort Smith$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.